Correlation of the clinicopathological findings with P4HA2 expression
| Characteristic . | P4HA2 expression in DLBCL . | ||
|---|---|---|---|
| Low (0, 1) . | High (2, 3) . | P . | |
| Age, y | |||
| ≤54 | 69 | 17 | .295 |
| >54 | 85 | 30 | |
| Sex | |||
| Female | 60 | 19 | .649 |
| Male | 96 | 26 | |
| DLBCL subtypes | |||
| GCB | 88 | 16 | .014 |
| Non-GCB | 68 | 29 | |
| p-Erk | |||
| Low (0-1) | 101 | 22 | .021 |
| High (2-3) | 48 | 23 | |
| IPI risk group | |||
| Low (0-1) | 86 | 15 | .006 |
| High (2-5) | 55 | 26 | |
| Characteristic . | P4HA2 expression in DLBCL . | ||
|---|---|---|---|
| Low (0, 1) . | High (2, 3) . | P . | |
| Age, y | |||
| ≤54 | 69 | 17 | .295 |
| >54 | 85 | 30 | |
| Sex | |||
| Female | 60 | 19 | .649 |
| Male | 96 | 26 | |
| DLBCL subtypes | |||
| GCB | 88 | 16 | .014 |
| Non-GCB | 68 | 29 | |
| p-Erk | |||
| Low (0-1) | 101 | 22 | .021 |
| High (2-3) | 48 | 23 | |
| IPI risk group | |||
| Low (0-1) | 86 | 15 | .006 |
| High (2-5) | 55 | 26 | |
Bold P values represent significant difference.